| Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review P Vaupel, F Kallinowski, P Okunieff Cancer research 49 (23), 6449-6465, 1989 | 4458 | 1989 |
| Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects M Hockel, P Vaupel Journal of the National Cancer Institute 93 (4), 266-276, 2001 | 3374 | 2001 |
| Tumor microenvironmental physiology and its implications for radiation oncology P Vaupel Seminars in radiation oncology 14 (3), 198-206, 2004 | 1203 | 2004 |
| The role of hypoxia-induced factors in tumor progression P Vaupel The oncologist 9 (S5), 10-17, 2004 | 1108 | 2004 |
| Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response P Vaupel, L Harrison The oncologist 9 (S5), 4-9, 2004 | 1017 | 2004 |
| The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression P Vaupel, H Schmidberger, A Mayer International journal of radiation biology 95 (7), 912-919, 2019 | 715 | 2019 |
| Oxygenation status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy P Vaupel, DK Kelleher, M Höckel Seminars in oncology 28, 29-35, 2001 | 689 | 2001 |
| Revisiting the Warburg effect: historical dogma versus current understanding P Vaupel, G Multhoff The Journal of physiology 599 (6), 1745-1757, 2021 | 616 | 2021 |
| Tumor hypoxia and malignant progression P Vaupel, A Mayer, M Höckel Methods in enzymology 381, 335-354, 2004 | 594 | 2004 |
| Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis P Vaupel The oncologist 13 (S3), 21-26, 2008 | 495 | 2008 |
